Cell Signaling - PowerPoint PPT Presentation

1 / 14
About This Presentation
Title:

Cell Signaling

Description:

... themselves (autophosphorylation), thus activating the catalytic activity of the receptor. ... This pathway will activate protein kinase B (PKB) ... – PowerPoint PPT presentation

Number of Views:49
Avg rating:3.0/5.0
Slides: 15
Provided by: allisonmil
Category:

less

Transcript and Presenter's Notes

Title: Cell Signaling


1
Cell Signaling
Lodish pgs. 534, 600, 618-619
2
  • A cell targeted by a particular chemical signal
    has a receptor protein that recognizes the signal
    molecule.

3
  • The response of a particular cell to a signal
    depends on the type of proteins it contains.

4
Seven major classes of membrane receptors
5
  • Insulin is a key player in both carbohydrate and
    lipid metabolism, and has significant influences
    on protein and mineral metabolism.
  • Defects in insulin signaling have widespread and
    devastating effects on many organs and tissues.
  • The amino acid sequence is highly conserved
    among vertebrates, and many diabetic patients are
    treated with insulin extracted from pig pancreas.

6
  • Insulin regulates blood glucose levels by
    increasing import of glucose by fat and muscle
    cells.
  • Glucose is liberated from dietary carbohydrate
    such as starch or sucrose by hydrolysis within
    the small intestine, and is then absorbed into
    the blood.
  • When blood glucose rises above its normal level,
    pancreatic b-cells release insulin into the blood.

7
  • The insulin receptor is a dimeric tyrosine
    kinase embedded in the plasma membrane.
  • Two alpha subunits-extracellular, have insulin
    binding domains.
  • Two beta subunits linked by disulfide
    bonds-within and on cytosolic side of membrane.

8
  • Binding of insulin to the alpha subunits causes
    the beta subunits to phosphorylate themselves
    (autophosphorylation), thus activating the
    catalytic activity of the receptor.

9
  • Several intracellular proteins have been
    identified as phosphorylation substrates for the
    insulin receptor, the best-studied of which is
    insulin receptor substrate 1 or IRS-1.
  • When IRS-1 is activated by phosphorylation, is
    serves as a type of docking center for
    recruitment and activation of other enzymes.

10
  • Activation of the insulin receptor will lead to
    the activation of the phosphatidylinositol-3
    kinase (PI-3K) pathway.
  • This pathway will activate protein kinase B
    (PKB).
  • PKB will inactivate glycogen synthetase 3 (GSK3)
    which normally inhibits glycogen synthase.
  • When glycogen synthase is active, glucose
    monomers are synthesized into long chains of
    glycogen (liver and muscle).

11
  • Protein kinase B causes movement of the GLUT4
    glucose transporter from intracellular membranes
    to the cell surface.
  • The influx of glucose will lower blood glucose
    levels.
  • When blood glucose levels return to normal, the
    GLUT4 transporters will be taken back into the
    cell by endocytosis.

PKB
12
  • When glucose levels in the blood rise
  • Your cells may be starved for energy.
  • Over time, high blood glucose levels can hurt
    your eyes, kidneys, nerves, and/or heart.

13
  • Diabetes mellitus is a metabolic disease that is
    characterized by abnormally high levels of
    glucose in the blood.
  • Type I or insulin-dependent diabetes is the
    result of a deficiency of insulin.
  • It is due to destruction pancreatic b-cells,
    most likely the result of autoimmunity to one or
    more components of those cells.
  • Usually begins in childhood.
  • Many of the acute effects of this disease can be
    controlled by insulin replacement therapy.

14
  • Diabetes mellitus is a metabolic disease that is
    characterized by abnormally high levels of
    glucose in the blood.
  • Type II or non-insulin-dependent diabetes begins
    as a syndrome of insulin resistance.
  • Target tissues fail to respond appropriately to
    insulin.
  • Typically, the onset of this disease is in
    adulthood.
  • Despite monumental research efforts, the nature
    of the defect has been difficult to ascertain -
    in some patients, the insulin receptor is
    abnormal, in others, one or more aspects of
    insulin signaling is defective, and in others, no
    defect has been identified.
  • The disease is controlled through dietary
    therapy and hypoglycemic agents.
Write a Comment
User Comments (0)
About PowerShow.com